Emerging Markets Service > Ems

Vaccine optimism reduces EM risks

The positive developments on Covid-19 vaccines are broadly in line with our baseline forecast for emerging markets – we expect a noticeable impact from mass vaccination programs from around mid-2021. Our in-house survey reveals the news has reduced downside risks for 2021 for the great majority of EMs.

To read the full briefing please
If you are not a subscriber, request a free trial of our Global Macro Service by filling out the form below